SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

S1 Biopharma, Inc. – IPO: ‘S-1’ on 10/1/14 – EX-23.2

On:  Wednesday, 10/1/14, at 5:26pm ET   ·   Accession #:  1047469-14-8020   ·   File #:  333-199111

Previous ‘S-1’:  None   ·   Next:  ‘S-1/A’ on 10/22/14   ·   Latest:  ‘S-1/A’ on 11/26/14

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of                Filer                Filing    For·On·As Docs:Size              Issuer               Agent

10/01/14  S1 Biopharma, Inc.                S-1                   19:3.9M                                   Merrill Corp/New/FA

Initial Public Offering (IPO):  Registration Statement (General Form)   —   Form S-1
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: S-1         Registration Statement (General Form)               HTML   1.18M 
 2: EX-3.1      Articles of Incorporation/Organization or By-Laws   HTML     38K 
 3: EX-3.2      Articles of Incorporation/Organization or By-Laws   HTML     69K 
 4: EX-3.3      Articles of Incorporation/Organization or By-Laws   HTML     93K 
 5: EX-3.4      Articles of Incorporation/Organization or By-Laws   HTML    123K 
 6: EX-10.1     Material Contract                                   HTML     89K 
15: EX-10.10    Material Contract                                   HTML     83K 
16: EX-10.11    Material Contract                                   HTML     29K 
17: EX-10.12    Material Contract                                   HTML     51K 
18: EX-10.13    Material Contract                                   HTML     35K 
 7: EX-10.2     Material Contract                                   HTML     45K 
 8: EX-10.3     Material Contract                                   HTML     31K 
 9: EX-10.4     Material Contract                                   HTML    137K 
10: EX-10.5     Material Contract                                   HTML    142K 
11: EX-10.6     Material Contract                                   HTML    137K 
12: EX-10.7     Material Contract                                   HTML     90K 
13: EX-10.8     Material Contract                                   HTML    119K 
14: EX-10.9     Material Contract                                   HTML     83K 
19: EX-23.2     Consent of Experts or Counsel                       HTML     10K 


EX-23.2   —   Consent of Experts or Counsel
Exhibit Table of Contents

Page (sequential) | (alphabetic) Top
 
11st Page   -   Filing Submission
"Exhibit 23.2
"Consent of Independent Registered Public Accounting Firm
"QuickLinks

This exhibit is an HTML Document rendered as filed.  [ Alternative Formats ]




QuickLinks -- Click here to rapidly navigate through this document


Exhibit 23.2

Consent of Independent Registered Public Accounting Firm

The Board of Directors
S1 Biopharma, Inc.:

        We consent to the use of our report included herein and to the reference to our firm under the heading "Experts" in the prospectus. Our report dated July 25, 2014 contains an explanatory paragraph that states that S1 Biopharma, Inc. has incurred recurring losses and negative cash flows from operations since inception and has an accumulated deficit at December 31, 2013 of $3.4 million which raises substantial doubt about its ability to continue as a going concern. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.

/s/ KPMG LLP

Philadelphia, Pennsylvania
October 1, 2014




QuickLinks

Consent of Independent Registered Public Accounting Firm

Dates Referenced Herein

This ‘S-1’ Filing    Date    Other Filings
Filed on:10/1/14None on these Dates
7/25/14
12/31/13
 List all Filings
Top
Filing Submission 0001047469-14-008020   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Wed., May 8, 4:28:42.1am ET